SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-015490
Filing Date
2018-11-13
Accepted
2018-11-13 16:01:09
Documents
43
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_wizepharmainc.htm 10-Q 426520
2 CERTIFICATION f10q0918ex31-1_wizepharma.htm EX-31.1 8958
3 CERTIFICATION f10q0918ex32-1_wizepharma.htm EX-32.1 4092
  Complete submission text file 0001213900-18-015490.txt   2907291

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE wizp-20180930.xml EX-101.INS 481514
5 XBRL SCHEMA FILE wizp-20180930.xsd EX-101.SCH 36611
6 XBRL CALCULATION FILE wizp-20180930_cal.xml EX-101.CAL 27824
7 XBRL DEFINITION FILE wizp-20180930_def.xml EX-101.DEF 147851
8 XBRL LABEL FILE wizp-20180930_lab.xml EX-101.LAB 336341
9 XBRL PRESENTATION FILE wizp-20180930_pre.xml EX-101.PRE 229735
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 181177833
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1